2025-06-14 04:31:06
Latest Post
ITC acquires shares of Sresta Natural Bioproducts Private Limited
Syngene International Ltd updates on USFDA inspection at Biocon Park, SEZ, Bengaluru
NTPC declares commercial operation of Unit 3 of North Karanpura Super Thermal Power Project
EPACK Durable Ltd awarded 'Best Overall Product' at Global LEAP Awards
IOL Chemicals and Pharmaceuticals Ltd registers Acetic Anhydride with REACH
Stock Report
Zenlabs Ethica Ltd Q4 FY2025 net profit at Rs. 9.07 lakhs
Posted On : 2025-05-12 19:32:45( TIMEZONE : IST )
Zenlabs Ethica Ltd has reported Standalone financial results for the period ended March 31, 2025.
Financial Results (Q4 FY2025) - QoQ Comparison
The company has reported total income of Rs. 13.0268 crores during the period ended March 31, 2025 as compared to Rs. 12.7255 crores during the period ended December 31, 2024.
The company has posted net profit / (loss) of Rs. 0.0907 crores for the period ended March 31, 2025 as against net profit / (loss) of Rs. 0.0851 crores for the period ended December 31, 2024.
The company has reported EPS of Rs. 0.14 for the period ended March 31, 2025 as compared to Rs. 0.13 for the period ended December 31, 2024.
| Financials | Q4 FY2025 | Q3 FY2025 | % Change |
| Total Income | ₹ 13.0268 crs | ₹12.7255 crs |  2.37% |
| Net Profit | ₹0.0907 crs | ₹0.0851 crs | 6.58% |
| EPS | ₹0.14 | ₹0.13 | 7.69% |
Financial Results (Q4 FY2025) - YoY Comparison
The company has reported total income of Rs. 13.0268 crores during the period ended March 31, 2025 as compared to Rs.15.3501 crores during the period ended March 31, 2024.
The company has posted net profit / (loss) of Rs.0.0907 crores for the period ended March 31, 2025 as against net profit / (loss) of Rs.0.1527 crores for the period ended March 31, 2024.
The company has reported EPS of Rs.0.14 for the period ended March 31, 2025 as compared to Rs.0.23 for the period ended March 31, 2024.
| Financials | Q4 FY2025 | Q4 FY2024 | % Change |
| Total Income | ₹ 13.0268 crs | ₹15.3501 crs |  -15.14% |
| Net Profit | ₹0.0907 crs | ₹0.1527 crs | -40.60% |
| EPS | ₹0.14 | ₹0.23 | -39.13% |
Financial Results (Year Ended FY2025) - YoY Comparison
The company has reported total income of Rs.51.4705 crores during the Financial Year ended March 31, 2025 as compared to Rs.58.8623 crores during the Financial Year ended March 31, 2024.
The company has posted net profit / (loss) of Rs.0.2692 crores for the Financial Year ended March 31, 2025 as against net profit / (loss) of Rs.0.4212 crores for the Financial Year ended March 31, 2024.
The company has reported EPS of Rs.0.41 for the Financial Year ended March 31, 2025 as compared to Rs.0.65 for the Financial Year ended March 31, 2024.
| Financials | Year Ended FY2025 | Year Ended FY2024 | % Change |
| Total Income | ₹51.4705 crs | ₹58.8623 crs | -12.56% |
| Net Profit | ₹0.2692 crs | ₹0.4212 crs | -36.09% |
| EPS | ₹0.41 | ₹0.65 | -36.92% |
Shares of Zenlabs Ethica Ltd was last trading in BSE at Rs. 31.99 as compared to the previous close of Rs. 31.38. The total number of shares traded during the day was 9156 in over 80 trades.
The stock hit an intraday high of Rs. 33.35 and intraday low of 31.06. The net turnover during the day was Rs. 289061.00.
